녹아웃(KO) 마우스 | Cyagen Korea

Citations

What Our Customers Say

“Among several commercial services who have claimed to be specialized to generate mouse models with genetic modifications, I recognize that Cyagen is one of the best. We are looking forward to having more cooperation with them.”

Korea Brain Research Institute (KBRI)

more ›

Contact Us

영업일 기준 1-2일 내에 답변해 드리겠습니다.

*

The username is required

*

The user's email is required

Please enter a valid email address.

*

The user's phone is required

Please enter a valid phone address.

*

The content is required

*

 

 

Strain Background: C57BL/6N

 

Construction Strategy:

The double-humanized PD-1 and CTLA-4 mouse model (hPD-1/hCTLA-4) was generated by intercrossing hPD-1 and hCTLA-4 mice.

 

hPD-1/hCTLA-4:

  •   The PD-1 and CTLA-4 extracellular domains are entirely humanized
  •   Physiological regulation and expression pattern of the human PD-1 and CTLA-4
  •   Preservation of the target-ligand interaction
  •   Fully functional mouse immune system
  •   Lack of expression of the murine target gene, thus avoiding cross-reactivity

 

Research and Application:

The hPD-1/hCTLA-4 mouse enables the in vivo efficacy and safety assessment of compounds targeting the human immune checkpoint PD-1 and/or VISTA in fully immunocompetent mice.

Use our hPD-1/hCTLA-4 mouse model together with cell line MC38-hPD-L1 as a syngeneic tumor model for testing the efficacy of combination therapies targeting human PD-1 and human PD-L1.

 

Validation Data:

Figure 1. hPD-1 and hCTLA-4 expression patterns in hPD-1/hCTLA-4 mice recapitulate mPD-1 and mCTLA-4 in wild-type mice. Splenocytes from wildtype and hPD-1/hCTLA-4 double homozygous mice were activated with αCD3/αCD29. Expression of both hPD-1 and hCTLA-4 in CD4conv T cells of hPD-1/hCTLA-4 mice, and mPD-1 and mCTLA-4 expression in CD4conv T cells of wildtype mice are shown.    

Figure 2. hPD-1 and hCTLA-4 are expressed on TILs (tumor-infiltrating lymphocytes). PD-1 and CTLA-4 expression on TILs from mice bearing MCA205 tumors. Mouse and human PD-1 and CTLA-4 expression were analyzed on wild-type and hPD-1/hCTLA-4 mice.

Figure 3. Intracranial transplantation of GL261 murine glioma cells into wild-type and hPD-1/hCTLA-4 homozygous mice. After transplantation, wild-type mice are treated with mouse PD-1 monoclonal antibody and injection of αhPD-1 (pembrolizumab) in hPD-1/hCTLA-4 homozygous mice to inhibit tumor growth and extend the lifespan of the mice.

Figure 4. Subcutaneous transplantation of MC38 murine colorectal cancer cells into wild-type and hCTLA-4 homozygous mice. In hCTLA-4 mice, treatment with αhCTLA-4 (ipilimumab) injection can inhibit tumor growth and prolong the life of mice.

위에 제품이나 서비스에 관심이 있으시면 저희한테 연락 부탁드립니다.

Your First Name can not be empty

Your Last Name can not be empty

Institution/Affiliation can not be empty

Please enter a valid email address.

Your Email can not be empty

The content can not be empty

The option can not be empty